YDES (YD Bio) FCF Margin %: 0.00% (As of Dec. 2025)


YDES YD Bio Ltd YDES
12 GF Score
Price $2.35
! 1 Warning Sign
View Full Analysis

What is YD Bio FCF Margin %?

YD Bio YDES -2.89% 12 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, YD Bio ranks worse than 81.23% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. YD Bio's Free Cash Flow for the six months ended in Dec. 2025 was $0.00 Mil. YD Bio's Revenue for the six months ended in Dec. 2025 was $0.60 Mil. Therefore, YD Bio's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, YD Bio's current FCF Yield % is -4.83%.

The historical rank and industry rank for YD Bio's FCF Margin % or its related term are showing as below:

YDES' s FCF Margin % Range Over the Past 10 Years
Min: -1346.23   Med: -810.59   Max: -16
Current: -1346.23

During the past 3 years, the highest FCF Margin % of YD Bio was -16.00%. The lowest was -1346.23%. And the median was -810.59%.

YDES's FCF Margin % is ranked worse than
81.23% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs YDES: -1346.23

YD Bio FCF Margin % Related Terms

YD Bio FCF Margin % Historical Data

* Premium members only.

The historical data trend for YD Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YD Bio FCF Margin % Chart

YD Bio Annual Data
Trend Dec23 Dec24 Dec25
FCF Margin %
-16.00 -810.59 -1,346.23

YD Bio Semi-Annual Data
Dec24 Jun25 Dec25
FCF Margin % 0.00 0.00 0.00

YDES vs NERV, CAMP, ARCT: FCF Margin % Comparison

For the Biotechnology subindustry, YD Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YD Bio FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, YD Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where YD Bio's FCF Margin % falls into.


YDES
12GF Score
YD Bio Ltd YDES
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

YD Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

YD Bio's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-8.037/0.597
=-1,346.23 %

YD Bio's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0.597
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
YD Bio (YDES) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on YD Bio and its competitors. According to the industry distribution chart, YD Bio ranks #779 out of 959 companies in the Biotechnology industry, placing it in the top 81.2%.
Is YD Bio's FCF Margin % too high?
YD Bio's current FCF Margin % is 0.00%. Based on the distribution chart, YD Bio ranks #779 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's FCF Margin % compare to NERV and CAMP?
According to the Biotechnology industry distribution chart, YD Bio ranks #779 out of 959 companies for FCF Margin %. This places YD Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on YD Bio and its competitors. YD Bio's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For YD Bio (YDES), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

YD Bio Business Description

Address No. 3, Xingnan Street, 12th Floor, Nangang District, Taipei City, TWN, 115001
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score

Get the complete analysis for YDES

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price